您当前的位置：
首页 >
文章列表页 >
Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells
更新时间：2025-05-30

    • Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells

      增强出版
    • “The latest research has found that the serum containing Shaoyao Tang can inhibit the apoptosis of intestinal epithelial cells in ulcerative colitis and reduce the content of inflammatory factors by regulating the Fas/FasL signaling pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 13, Pages: 62-69(2025)

    • DOI：10.13422/j.cnki.syfjx.20250404    

      CLC： R285;R289;R259

    • Received：19 December 2024，

      Published Online：06 March 2025，

      Published：05 July 2025

    移动端阅览

  • YANG Yuting,WU Dongsheng,CAO Hui,et al.Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(13):62-69. DOI： 10.13422/j.cnki.syfjx.20250404.

  •  
  •  

0

Views

67

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Shaoyaotang Restores Th17/Treg Cell Balance by Regulating Glucose Metabolism Reprogramming in Treatment of Ulcerative Colitis
Shaoyaotang Regulates Glucose Metabolism Reprogramming to Inhibit Macrophage Polarization Toward M1 Phenotype
Alleviation of Ulcerative Colitis by Shaoyaotang via Inhibiting Glycolysis Through SIRT6/HIF-1α Pathway
Mechanism of Shaoyaotang in Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification
Shaoyaotang Alleviates Ulcerative Colitis by Regulating Th17/Treg Balance Through IL-6/STAT3 Signaling Pathway

Related Author

XIAO Youwei
WANG Yiwen
XIA Yiling
JIANG Shaijin
CHENG Qi
XIA Yiling
CAO Hui
WU Dongsheng

Related Institution

School of Life Sciences， Beijing University of Chinese Medicine
Dongzhimen Hospital，Beijing University of Chinese Medicine
Hunan University of Chinese Medicine
Nanjing Medical University
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
0